Calendar Notable Labs, Ltd.

Equities

End-of-day quote Nasdaq Other stock markets 18:00:00 2024-04-25 EDT			5-day change	1st Jan Change
0.965 ^USD	+0.51%		-1.03%	-48.94%

04-15	Chardan Cuts Price Target on Notable Labs to $7 From $9, Keeps Buy Rating	MT
04-15	Chardan Cuts Price Target on Notable Labs to $7 From $9 on Higher Projected Future Share Count, Keeps Buy Rating	MT

c488.Y-S8vE7hAp-TDQXYtxPhSh0C-uazeDIelGhVMEdB7no.DJTf8Q-bOtjcXGbt3CWkK1RdsYPcIAsn5kUAez0Znkwa0-jwfLl49cdOVA~ea4354c542bdf5f5b5fe7e5798fab7a2

No events available

2024-04-12 08:00	Q4 2023 Earnings Release
2024-04-09 12:00	American Association for Cancer Research Meeting - Abstract No:5178
2024-04-08 12:00	American Association for Cancer Research Meeting - Abstract No:2548
2023-05-15 16:01	Q1 2023 Earnings Release
2023-03-14 08:00	Q4 2022 Earnings Release
2023-02-23 08:30	Vascular Biogenics Ltd. and Notable Labs Merger Call
2022-11-14 16:05	Q3 2022 Earnings Release
2022-08-15 16:05	Interim 2022 Earnings Release
2022-06-08 15:00	Jefferies Healthcare Conference
2022-06-02	American Society of Clinical Oncology Meeting
2022-05-22	H.C. Wainwright Global Life Sciences Investment Conference
2022-05-17 08:30	Q1 2022 Earnings Call
2022-05-17 07:00	Q1 2022 Earnings Release
2022-05-12 02:30	Biomed Israel Conference
2022-05-11 13:00	LifeSci Partners Immunology & Inflammation Symposium
2022-05-08 17:30	IMMUNOLGY Meeting
2022-04-11 12:00	Investor Meeting - KOL
2022-03-23 08:30	FY 2021 Earnings Call
2022-03-23 07:00	FY 2021 Earnings Release
2022-03-16 08:40	Oppenheimer Healthcare Conference

Fiscal Period	December	2022	2023	2024
Net sales Million USD	Released Forecast Spread	0,00	0,31 0,00 -	0,00
EBITDA	Released Forecast Spread	0,00	0,00 0,00 -	0,00
EBIT Million USD	Released Forecast Spread	0,00	-14,7 -14,5 -1.03%	-16,8
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00	-11,3 -14,5 22.33%	-16,8
Net income Million USD	Released Forecast Spread	-14,4	-11,3 -14,5 22.33%	-14,5
EPS USD	Released Forecast Spread	-1,38	-3,41 -1,62 -110.49%	-1,50
Announcement Date		01/09/23	11/04/24	-

Fiscal Period	December	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1
Net sales Million USD	Released Forecast Spread	0,12 0,00 -	0,19 0,00 -	0,00	0,00	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	-1,75 -3,71 52.78%	-4,40 -3,88 -13.48%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	2,89 -3,71 178.06%	-4,45 -3,87 -14.9%
Net income Million USD	Released Forecast Spread	2,89 -3,71 178.06%	-4,45 -3,87 -14.9%
EPS USD	Released Forecast Spread	0,19 -0,41 146.34%	-2,97 -0,43 -590.7%	-0,39	-0,43	-0,52	-0,56	-0,60
Announcement Date		29/11/23	11/04/24	-	-	-	-	-

2024-04-29	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29	ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29	MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29	WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 16:05	EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30	SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30	MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
2024-04-30	DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 07:00	NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release

Today	HITGEN INC.: Q1 2024 Earnings Release (Projected)
Today	CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-25	INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25	SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25	REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 16:05	PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30	SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release